Thermo Fisher Scientific Inc (TMO) Stock Forecast
US · Healthcare
Current price
$505.75
Market cap
$187.95B
Mean price target
$599.19
Implied upside
18.5%
Key takeaways
- Analysts rate Thermo Fisher Scientific Inc a “Buy”, with a mean price target of $599.19 — about 18.5% upside from the current $505.75, based on 26 analysts.
- TMO is trading in the middle of its 52-week range, at 43% of the $401.45–$643.99 band.
Analyst consensus
| Consensus rating | Buy |
|---|---|
| Number of analysts | 26 |
| Mean target | $599.19 |
| High target | $750.00 |
| Low target | $490.00 |
| Rating split (SB / B / H / S / SS) | 6 / 19 / 3 / 0 / 0 |
Price & trading
| Current price | $505.75 |
|---|---|
| Previous close | $492.20 |
| 52-week high | $643.99 |
| 52-week low | $401.45 |
| 50-day average | $475.17 |
| Beta | 0.87 |
See the full TMO breakdown on Luminoso
Valuation, profitability, efficiency, leverage & earnings-quality metrics — updated daily.
Start free — 2 months on usFrequently asked questions
- What is the current Thermo Fisher Scientific Inc (TMO) share price?
- Thermo Fisher Scientific Inc last traded at $505.75 with a market capitalisation of about $187.9B.
- What is the analyst price target for TMO?
- The mean analyst price target for Thermo Fisher Scientific Inc is $599.19, roughly 18.5% above the latest price. The current consensus rating is “Buy”.
- Where can I see Thermo Fisher Scientific Inc's full financial metrics?
- Luminoso tracks TMO's valuation, profitability, efficiency, leverage and earnings-quality metrics alongside analyst data — updated daily. Create a free account to explore the full breakdown.
More stocks
Browse all companies covered by Luminoso →
Last updated 25 Jun 2026.
Data is provided for informational purposes only and is not investment advice. Figures are cached and refreshed daily; they may differ from real-time quotes.